SCHEMBL4962798

SCHEMBL4962798

COCCOCc1cn(Cc2ccc(F)cc2)c2cnc3c(c12)CCN(O)C3=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 1/20 0.34
▸ LMNA P02545 5/20 0.33
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ L3MBTL1 Q9Y468 3/20 0.33
▸ HTT P42858 3/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ KMT2A Q03164 4/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ PDE4A P27815 1/20 0.32
▸ PDE4B Q07343 1/20 0.32
▸ PDE4C Q08493 1/20 0.32
▸ PDE4D Q08499 1/20 0.32
▸ NCOA3 Q9Y6Q9 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ KLKB1 P03952 3/20 0.32
▸ FSCN1 Q16658 1/20 0.31
▸ CACNB4 O00305 1/20 0.31
▸ CACNA1A O00555 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4966779 0.93 PKM (0.37) PKMLMNASMN1; SMN2L3MBTL1HTT
SCHEMBL4962397 0.92 PKM (0.35) PKMLMNASMN1; SMN2L3MBTL1HTT
SCHEMBL5421018 0.91 PKM (0.33) PKMLMNASMN1; SMN2L3MBTL1HTT
SCHEMBL4964902 0.91 PKM (0.34) PKMLMNASMN1; SMN2L3MBTL1HTT
SCHEMBL4966404 0.91 PKM (0.33) PKMLMNASMN1; SMN2L3MBTL1HTT
SCHEMBL4962824 0.91 PKM (0.33) PKMLMNASMN1; SMN2L3MBTL1HTT
SCHEMBL4964610 0.91 SMN1; SMN2 (0.41) LMNASMN1; SMN2L3MBTL1HTTALDH1A1
SCHEMBL4962937 0.91 PKM (0.35) PKMLMNASMN1; SMN2L3MBTL1HTT
SCHEMBL4962946 0.90 PKM (0.36) PKMLMNASMN1; SMN2L3MBTL1HTT
Hydrochloric Acid SCHEMBL4964708 0.89 PKM (0.36) PKMLMNASMN1; SMN2L3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1934220-A1 INHIBITORS OF THE HIV INTEGRASE ENZYME Pfizer Products Incorporated (US) 2008-06-25 — — EP disclosed
US-20070099915-A1 INHIBITORS OF THE HIV INTEGRASE ENZYME PFIZER INC. 2007-05-03 — — US disclosed
US-20070099915-A1 INHIBITORS OF THE HIV INTEGRASE ENZYME PFIZER INC. 2007-05-03 — — US disclosed
US-20070099915-A1 INHIBITORS OF THE HIV INTEGRASE ENZYME PFIZER INC. 2007-05-03 — — US disclosed
WO-2007042883-A1 INHIBITORS OF THE HIV INTEGRASE ENZYME PFIZER PRODUCTS INC. (US) 2007-04-19 — — WO disclosed
WO-2007042883-A1 INHIBITORS OF THE HIV INTEGRASE ENZYME PFIZER PRODUCTS INC. (US) 2007-04-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099915-A1 INHIBITORS OF THE HIV INTEGRASE ENZYME IMPDH1, INTS9, TYMP PKM 1971/4885LMNA 3259/4885SMN1; SMN2 4080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback